Showing results (181-190 of 1,028) with videos related to
Sort By:
Pageof 103
Journal of Cardiovascular Pharmacology and Therapeutics|October 20, 2020
Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19Husam M Salah, Jawahar L MehtaCirculation|June 1, 1987
Acute myocardial ischemia: role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolismC R Conti, J L MehtaCurrent Opinion in Critical Care|October 12, 2020
Identification of acute kidney injury subphenotypesZoltan H Endre, Ravindra L MehtaDrug Intelligence & Clinical Pharmacy|December 1, 1985
Long-term experience with lofexidine in the treatment of mild-to-moderate essential hypertensionL M Lopez, J L MehtaCurrent Opinion in Cardiology|August 12, 2005
C-reactive protein and cardiovascular disease: a critical appraisalJorge L Sepulveda, Jawahar L MehtaAmerican Journal of Nephrology|July 7, 1999
Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on DialysisR L Mehta, J M LetteriIndian Heart Journal|January 5, 2002
Interactions between the renin-angiotensin system and dyslipidemia: relevance in atherogenesis and therapy of coronary heart diseaseB K Singh, J L MehtaCurrent Opinion in Cardiology|October 3, 2002
Management of dyslipidemia in the primary prevention of coronary heart diseaseBalkrishna K Singh, Jawahar L MehtaArchives of Internal Medicine|June 11, 2003
Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart diseaseBalkrishna M Singh, Jawahar L MehtaJournal of Cardiovascular Pharmacology and Therapeutics|September 3, 2009
Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1Bum-Yong Kang, Jawahar L MehtaPageof 103